42
Participants
Start Date
August 10, 2017
Primary Completion Date
January 16, 2018
Study Completion Date
January 16, 2018
BI 1015550
Part 1 - single rising dose. Part 2 multiple rising dose
Placebo
Part 1 - single rising dose. Part 2 multiple rising dose
CRS Clinical Research Services Mannheim GmbH, Mannheim
Lead Sponsor
Boehringer Ingelheim
INDUSTRY